circ-C20orf11通过miR-495-3p促进卡里奥菲林α2表达,并影响非小细胞肺癌的发展
1Department of Thoracic and Cardiovascular Surgery, Shenzhen Guangming District People's Hospital, Shenzhen City, Guangdong Province, China. dr.wu829xuanqin@outlook.com.
概括
循环RNA C20orf11 (circ-C20orf11) 通过与microRNA 495-3p (miR-495-3p) 和卡里奥菲林α2 (KPNA2) 相互作用,促进非小细胞肺癌 (NSCLC) 的进展. 这个轴加速瘤生长和转移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 非小细胞肺癌 (NSCLC) 是一种具有高死亡率的侵袭性恶性瘤.
- 在NSCLC中,循环RNA的特定作用和机制,如circ-C20orf11,仍然在很大程度上未被探索.
- 了解新的分子通路对于开发向疗法至关重要.
研究的目的:
- 研究NSCLC中circ-C20orf11的表达和功能.
- 阐明circ-C20orf11影响NSCLC细胞行为的分子机制.
- 在circ-C20orf11路径中识别潜在的治疗点.
主要方法:
- 使用定量实时PCR来评估NSCLC组织中的circ-C20orf11表达水平.
- 进行了体外测试,以评估circ-C20orf11操纵对NSCLC细胞增殖,亡,迁移和入侵的影响.
- 用路西法酶记者测定和西部抹杀来验证circ-C20orf11,miR-495-3p和KPNA2.2之间的向相互作用.
主要成果:
- 与正常对照组相比,NSCLC组织中的Circ-C20orf11表达显著上调.
- 沉默circ-C20orf11抑制NSCLC细胞的增殖,迁移和入侵,同时促进细胞亡.
- Circ-C20orf11作为miR-495-3p的分子海绵,导致KPNA2的表达增加,这反过来又促进了NSCLC的进展.
结论:
- Circ-C20orf11在促进NSCLC的侵袭性进展方面发挥着至关重要的作用.
- 环-C20orf11/miR-495-3p/KPNA2轴代表了NSCLC的一个新型调节途径.
- 针对circ-C20orf11通路可能为NSCLC治疗提供潜在的治疗策略.
相关概念视频
MicroRNAs
2.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
2.9K
The Nucleolus
8.6K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.6K
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K


